NT Factor and Membrane Lipid Replacement: What the Evidence Actually Shows

CoQ10, magnesium, B vitamins, D-ribose: if you have been chasing fatigue, you have likely worked through that list. The next place to look is one layer deeper, at the membranes those nutrients work inside.

NT Factor and its category, membrane lipid replacement, target the fat your mitochondria are built from. The mechanism is well supported. The marketing does not always tell the whole story, and the trials used several times the dose a typical capsule delivers.

Table of Contents

• What Is NT Factor?
• Your Cell Membrane Is a Phospholipid Bilayer
• How Oxidized Membrane Lipids Lower ATP Output
• Who Wrote This Research
• What the NT Factor Fatigue Trials Actually Found
• The One Controlled Trial, and Why the Washout Matters
• The Evidence That Did Not Come From the Manufacturer
• The Dose Reality: Grams, Not Milligrams
• How to Read a Phospholipid Label
• Is NT Factor Safe?
• An Honest Bottom Line
• What We Recommend
• Frequently Asked Questions
• References

What Is NT Factor?

NT Factor is a proprietary blend of glycerophospholipids, the fat molecules your cell membranes are built from. It sells as NTFactor and appears in practitioner formulas built on membrane lipid replacement, or MLR. The premise: membranes collect damage, and intact phospholipids give them fresh raw material.

It is a structural ingredient, not a vitamin or an herb, which is why it gets discussed alongside nutrients like CoQ10 rather than instead of them. The phospholipid dose changes with the formula around it.

Your Cell Membrane Is a Phospholipid Bilayer

A cell membrane is two layers of fat molecules arranged tail to tail. Water-loving heads face out toward the surroundings and inward toward the cytoplasm. Water-fearing tails meet in the middle and form the barrier.

That is the fluid-mosaic model, described fifty years ago and still the working picture [6]. Proteins float in the lipid sea rather than resting on it. Lipids are not packing material: they set stiffness, how easily ions cross, and how well embedded proteins fold.

The classes do different jobs. Phosphatidylcholine is structural, phosphatidylethanolamine shapes curvature, phosphatidylserine handles cell signaling, cardiolipin sits almost exclusively in the inner mitochondrial membrane, and plasmalogens, ether lipids at roughly 15 to 20 mol% of tissue phospholipids, act as built-in antioxidants [3].

A blend built mostly from one phospholipid is not the same product as a blend spread across several. Plasmalogens have their own trial literature, covered in the plasmalogen guide.

How Oxidized Membrane Lipids Lower ATP Output

The inner mitochondrial membrane is where the real work happens. The electron transport chain sits in it and works by pumping protons across it.

That membrane is rich in polyunsaturated fatty acids, which are vulnerable to reactive oxygen and nitrogen species. When they oxidize:

1. Membrane lipids take oxidative damage.
2. Oxidized lipids change how tightly the membrane packs.
3. The membrane becomes leakier to protons and ions.
4. The trans-membrane potential falls as the gradient leaks away.
5. Less gradient means less driving force, and ATP output drops.

That sequence is the mechanism membrane lipid replacement aims at [1]. It comes from the review literature below, so attach the same caution to it as to the trial numbers.

Cardiolipin shows the principle is real: a 2026 study in eLife found cardiolipin deficiency disrupts the electron transport chain [4]. That is basic science, not a supplement trial.

The membrane is not a passive bag. It is the surface the whole energy-conversion apparatus is mounted on, and its fat composition sets how well that apparatus holds its charge.

Who Wrote This Research

This is the part the manufacturer's own papers state and that promotional copy tends not to lead with.

Almost the entire human evidence base traces back to two authors, Garth Nicolson and Robert Settineri. Both are paid consultants to the company that makes NTFactor. They disclose it in print:

• The 2016 review: "Conflict of interests: Garth Nicolson and Robert Settineri are part-time consultants to Nutritional Therapeutics, Inc. ..." [1]
• The 2021 review: "G.L.N. and R.S. are part-time consultants to Nutritional Therapeutics, Inc." [2]
• The funding line in that same review: "G.L.N. acknowledges support from the Institute for Molecular Medicine and Nutritional Therapeutics, Inc." [2]

Nutritional Therapeutics, Inc. makes NTFactor. The marquee evidence was produced by people on its payroll, part-funded by it.

A disclosed conflict does not make data false. It does mean nobody without a stake has independently checked these findings, which is a lower grade of evidence than a trial from an unaffiliated lab.

That splits the evidence in two. Tier 1 is independent work from other labs. Tier 2 is the NT Factor fatigue trials: small, mostly open-label, produced by the authors above.

What the NT Factor Fatigue Trials Actually Found

Nine fatigue trials appear in the 2016 review [1]. The real numbers, which the marketing pages do not publish:

Supplement	Condition studied	Participants	Mean age	Fatigue reduction
Propax / NTFactor	Chronic fatigue	34	50.3	40.5%
NTFactor	Aging, chronic fatigue	22	68.9	35.5%
NTFactor	CFS / fibromyalgia	15	44.8	43.1%
Healthy Curb	Obesity, fatigue	35	42	23.9%
APF / NTFactor	Aging, chronic fatigue	67	57.3	36.8%
Propax / NTFactor	Cancer, fatigue	35	50.7	30.1%
ATP Fuel / NTFactor	CFS / ME	30	55	30.7%
ATP Fuel / NTFactor	Gulf War Illness	16	42.2	34.6%
ATP Fuel / NTFactor	Lyme disease	17	52.4	26.0%

The reported range of fatigue reduction is 26 to 43 percent [1]. Trials ran 8 to 12 weeks, and most were small, under 50 participants, and open-label, which the review itself states [1]. The condition column describes who each study enrolled, not what any product is for.

Fatigue was measured by questionnaire, on the Piper Fatigue Scale. Someone who knows they are taking an experimental supplement, then rates their own tiredness, is not a neutral instrument. Read the table as a signal, not a verdict.

Participants in the ATP Fuel studies had been ill over 17 years on average and had tried more than 35 supplements or drugs without effect. Fatigue fell significantly within 6 weeks (p<0.0001), with regression values of 0.960 to 0.998 [1]. Striking in a hard-to-treat group, and uncontrolled, which is where expectation produces large effects.

The One Controlled Trial, and Why the Washout Matters

One study used a cross-over design, which makes it the most informative single finding here.

Agadjanyan and colleagues gave 22 participants, average age 68.9, a 4 g daily dose for 8 weeks [1]. By 12 weeks, mitochondrial function, measured as inner mitochondrial membrane redox potential, was comparable to that of young healthy adults, a 26.8 percent increase (p<0.0001), and fatigue fell 35.5 percent (p<0.001).

Participants then moved onto a blinded placebo for 12 more weeks. Both fatigue and mitochondrial function ended up intermediate between the starting values and the treated values [1]. Function drifted back toward baseline when the supplement stopped, but not all the way back. That is the shape a real biological effect makes as it fades.

It is not proof; 22 people with a subjective endpoint cannot be. But the washout pattern separates a plausible mechanism from a marketing claim. The fatigue endpoint is a questionnaire, and the mitochondrial measure is a proxy marker, not a clinical outcome.

The Evidence That Did Not Come From the Manufacturer

None of this depends on Nicolson or Settineri.

Phosphatidylserine, in an independent lab. A 2026 randomized, double-blind, placebo-controlled trial in the Journal of Applied Physiology gave 900 mg per day for 4 weeks to people with type 2 diabetes, about 280 mg per day of actual phosphatidylserine [7]. The outcomes were vascular: better leg blood flow after glucose, reduced aortic pulse wave velocity, less vascular oxidative stress. It is here because a phospholipid produced measurable oxidative-stress and vascular effects in a controlled design, in an unaffiliated lab.

Plasmalogens, in a randomized trial. A 2026 trial in Frontiers in Nutrition screened 168 people, randomized 68, and analyzed 66, all cognitively healthy adults aged 40 and over with below-average verbal memory [8]. They took 1 mg per day of scallop-derived plasmalogens for 12 weeks, and verbal memory beat placebo by an estimated marginal mean difference of 10.1 (95% CI 0.4 to 19.9, p=0.042). Not NT Factor, but a membrane lipid class tested independently, with a placebo arm.

Choline, honestly bounded. A 2026 scoping review of 117 primary studies found the evidence "insufficient or equivocal for many health outcomes" [5]. Nobody has established that dietary phospholipid intake is provably insufficient for everyone. Our detox and methylation resource page covers how choline and methylation connect.

The concept predates any product. "Plasmalogen replacement therapy" is a term used by independent researchers, including a McMaster University review [9].

The Dose Reality: Grams, Not Milligrams

The fatigue trials used 4 grams of phospholipids per day, the dose in the cross-over trial [1][2]. The fibromyalgia pain work used 4.8 g for 8 days, and pain responses were better and more durable at or above 6 g [2].

A typical phosphatidylcholine capsule delivers a few hundred milligrams to about 1,200 mg. Not grams. Milligrams.

Run the division before you buy. At 4 grams per day, a product delivering 500 mg per capsule would need eight capsules daily just to reach the dose used in the trials.

A capsule that looks expensive per bottle may be cheap per gram, and one that looks reasonable may be impossible to dose to the studied level. A product that prints its phospholipid number in grams is the exception. XYMOGEN PhosphaLine states 2.7 g per serving, which is the kind of figure that survives the division above.

1. Compare cost per gram of phospholipid, not cost per bottle.
2. Check phospholipid content, not total capsule weight. A 1,200 mg softgel is not 1,200 mg of phospholipids unless the label says so.

Higher loads mean more capsules, worth discussing with your clinician. Delivery format is a separate lever, and our guide to liposomal supplements explains how absorption routes differ. Nothing here is a dosing instruction, only a record of what the trials used.

How to Read a Phospholipid Label

Most products print one number, "phosphatidylcholine," and stop there, which hides a lot. The NT Factor composition is disclosed in the 2016 review [1]:

Phospholipid	Share of the blend
Phosphatidylcholine (PC)	31.6%
Phosphatidylinositol (PI)	24.9%
Phosphatidylethanolamine (PE)	18.9%
Phosphatidic acid	13.9%
Digalactosyl-diacylglycerol	5.9%
Phosphatidylglycerol (PG)	2.4%
Lysophosphatidylcholine	1.0%
Phosphatidylserine (PS)	0.5%
Monogalactosyldiacylglycerol	0.3%

Phosphatidylcholine is under a third of it, and the blend was assembled to mirror mitochondrial lipid composition rather than maximize one fraction [1]. The fatty acid profile is disclosed too: linoleic acid 58.4%, palmitic 19.4%, oleic 9.7%, linolenic 5.9%, stearic 3.9% [1].

If what you are actually after is choline status rather than membrane lipid dose, that is a different question with different products, and the choline supplement guide covers the forms and what each was studied for. This guide is about the membrane, not about choline intake.

What to check on any label

• Total phospholipids, or only PC? Total is the number that matters for dose comparison.
• Classes listed, or just one? A blend and a single-fraction product behave differently.
• Is the source stated? Many phospholipid products are soy-derived, which matters with a soy allergy.
• Per capsule or per serving? Some labels quote two capsules as one serving.

Is NT Factor Safe?

First the caveat: the safety data comes from the same conflicted review [2]. There is no independent safety study in this set.

What it reports:

• No acute or chronic toxicity found, even at very high daily doses [2].
• Animal doses up to 3.75 g per kg of body weight per day produced no measurable toxic, mutagenic, or carcinogenic events, and no toxic or lethal dose could be established [2].
• Up to 45 g given orally to humans with no adverse effects reported [2].
• Pregnant rats and rabbits at up to and above 1 g per kg showed no toxicity in the mothers or the newborns [2].

Wide margins, reported by the ingredient's own consultants. Reassuring, not conclusive.

Who should check with a clinician first

• Blood thinners or a bleeding disorder. Phospholipid and phosphatidylserine products can affect platelet function.
• Soy allergy. Many phospholipid products are soy-derived.
• Cholinesterase inhibitors. Phospholipid intake interacts with choline handling.
• Pregnant or nursing, without a clinician's sign-off.

Not a complete list, and not medical advice. Bring the bottle to your clinician and ask.

An Honest Bottom Line

The mechanism is well supported. Membranes are built from phospholipids, lipid composition affects how well they hold a charge, and cardiolipin biology shows mitochondrial energy production depends on the right lipids being present [4]. None of that rests on the conflicted literature.

The NT Factor fatigue evidence is promising and weak at once. Nine trials report 26 to 43 percent fatigue reductions, the cross-over washout behaves the way a real effect would, and all of it comes from a small, mostly open-label body of work by paid consultants to the manufacturer [1][2].

The strongest human membrane lipid evidence comes from other phospholipids in other labs. Phosphatidylserine in a controlled vascular trial and plasmalogens in a controlled memory trial were run independently, and neither used the NT Factor blend [7][8].

If you have already worked through the standard cellular energy nutrients, buy on composition and cost per gram rather than on the story, give it 8 to 12 weeks, and track your own fatigue honestly. Do not pay a premium for the boldest headline on the bottle. The evidence here does not support one.

What We Recommend

Every product below is stocked by Agape Nutrition and maps to the dose and form points above. Compare the phospholipid number first, then the price.

Researched Nutritionals, ATP Fuel 150 Capsules

ATP Fuel is the formula built on the NTFactor phospholipid blend, and it is the formula those trial rows above were run on. Naming it here is trial-design information, not a claim about results or about any condition, and the evidence caveat from earlier applies to it unchanged. Alongside the stabilized phospholipids it carries stabilized NADH and CoQ10. The label protocol is five capsules twice daily for the first two months, so a 150 capsule bottle covers about two weeks at that intake. It contains ingredients derived from soy.

$71.98

Researched Nutritionals, ATP 360, 90 Capsules

The blend option. ATP 360 pairs a proprietary phospholipid matrix (phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol and phytoglycolipids) with the Krebs cycle and electron transport cofactors: R-lipoic acid, PQQ, NADH, CoQ10, magnesium, thiamine and acetyl-carnitine. Pick it when you want the phospholipids and the standard cellular energy nutrients in one formula instead of layering them separately.

$72.98

XYMOGEN, PhosphaLine 100 Softgels

The single-fraction option, and the closest thing here to the gram doses the trials used: 2.7 g of polyenylphosphatidylcholine per serving, with up to 52 percent of that as DLPC and roughly 130 mg of choline per softgel. It contains no other phospholipids, which is a deliberate design choice rather than an omission. Directions are two to three softgels daily. Soy derived, so it is not the pick if you avoid soy.

$158.99

XYMOGEN, PhosphaLine Liquid 8 oz

The same single-fraction phosphatidylcholine in liquid form, 3 g per serving, one teaspoon daily. It is the highest phospholipid dose per serving on this list and the practical choice if you would rather not take several softgels a day. Soy derived as well.

$249.99

One product is missing from this list on purpose. The standalone NT Factor Energy product (Researched Nutritionals, NT Factor Energy 90 Tablets) has been archived and is no longer sold here, so ATP Fuel is the current NT Factor-based formula the store carries. We would rather say that plainly than point you at something you cannot buy.

A reminder on the math, because it is the point of this guide. The fatigue trials used 4 g of phospholipids per day, and the pain studies went higher [1][2]. A 2.7 g serving of phosphatidylcholine is a real contribution toward that figure. A 500 mg capsule is not, at least not without eight of them. Cost per gram of phospholipid is the number to compare across bottles, not the price on the shelf. None of this is a dosing instruction, and anyone on blood thinners, managing a bleeding disorder, avoiding soy, or taking a cholinesterase inhibitor should talk with their clinician before adding anything.

Frequently Asked Questions

What is NT Factor, in plain terms?

A proprietary blend of glycerophospholipids sold as NTFactor, and the base ingredient in membrane lipid replacement formulas. It is designed to mirror mitochondrial lipid composition rather than concentrate one phospholipid [1].

What are NT Factor side effects?

The published safety work reports no acute or chronic toxicity and no adverse effects up to 45 g given orally to humans [2], though that data comes from the same conflicted review. Anyone on blood thinners, a bleeding disorder, a soy allergy, or cholinesterase inhibitors should check with their clinician first.

Does membrane lipid replacement actually work?

The mechanism is credible and independently supported. The specific fatigue results are real but small, open-label, and produced by authors with a disclosed financial tie to the manufacturer [1][2]. The cleanest controlled evidence comes from phosphatidylserine and plasmalogen trials in other labs [7][8].

What phosphatidylcholine dosage should I take?

That is a conversation for your clinician. What the research used: 4 grams of phospholipids per day in the fatigue trials over 8 to 12 weeks, 4.8 grams per day for 8 days in the fibromyalgia pain study, and at or above 6 grams per day in the pain case studies [1][2]. A typical capsule provides a few hundred milligrams to about 1,200 mg.

Which form of phospholipid supplement is best?

One that states total phospholipids rather than PC alone, lists the phospholipid classes, names its source, and quotes the dose per capsule. The disclosed NT Factor blend is about 31.6 percent PC, 24.9 percent PI, and 18.9 percent PE [1].

How long until it works?

The fatigue trials ran 8 to 12 weeks, and the cross-over trial showed mitochondrial changes by 8 weeks [1]. Give any phospholipid protocol two to three months.

Is NT Factor safe to take long term?

The available safety data suggests a wide margin, from the ingredient's own consultants rather than an independent group [2]. Long-term independent safety data does not exist. Anyone pregnant, nursing, on blood thinners, or managing a bleeding disorder should treat this as a clinician conversation.

References

1. Nicolson GL, Rosenblatt S, de Mattos GF, Settineri R, et al. Clinical Uses of Membrane Lipid Replacement Supplements in Restoring Membrane Function and Reducing Fatigue in Chronic Diseases and Cancer. Discoveries (Craiova). 2016. PMCID PMC6941554. https://pmc.ncbi.nlm.nih.gov/articles/PMC6941554/
2. Nicolson GL, Ferreira de Mattos G, Ash M, Settineri R, Escribá PV. Fundamentals of Membrane Lipid Replacement: A Natural Medicine Approach to Repairing Cellular Membranes and Reducing Fatigue, Pain, and Other Symptoms While Restoring Function in Chronic Illnesses and Aging. Membranes. 2021. PMCID PMC8707623. https://pmc.ncbi.nlm.nih.gov/articles/PMC8707623/
3. Wu Y, Deng Y, Angelov B, Angelova A. Plasmalogen as a Bioactive Lipid Drug: From Preclinical Research Challenges to Opportunities in Nanomedicine. FASEB BioAdvances. 2025. PMID 40746866, PMCID PMC12312521.
4. Brothwell MJ, Cao G, Maschek JA, Poss AM, et al. Cardiolipin deficiency disrupts electron transport chain and drives steatohepatitis. eLife. 2026. PMID 42684124, PMCID PMC13537762.
5. Yoo S, Aoun A, Montazeri A, Collins E, Little J. Choline status and related health outcomes in humans: A scoping review. Nutrition and Health. 2026. PMID 41847819, PMCID PMC13538934.
6. Nicolson GL, Ferreira de Mattos G. Fifty Years of the Fluid-Mosaic Model of Biomembrane Structure and Organization and Its Importance in Biomedicine with Particular Emphasis on Membrane Lipid Replacement. Biomedicines. 2022. PMID 35885016, PMCID PMC9313417.
7. McMillan NJ, Augenreich MA, Ramirez-Perez FI, Power G, et al. Beneficial vascular effects of oral phosphatidylserine supplementation in type 2 diabetes. Journal of Applied Physiology. 2026. PMID 42312814, PMCID PMC13404116.
8. Fukuchi M, Tanaka M, Nagata M, Takara T, Sasuga Y. Orally administered scallop-derived plasmalogens improve cognitive function in healthy middle-aged and older adults: a randomized, double-blind, placebo-controlled trial. Frontiers in Nutrition. 2026. PMID 42656342, PMCID PMC13506472.
9. Bozelli JC, Epand RM. Plasmalogen Replacement Therapy. Membranes. 2021. PMID 34832067, PMCID PMC8620983.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.